Compare BJDX & HLSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJDX | HLSQ |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 865.6K | 972.0K |
| IPO Year | 2021 | 2018 |
| Metric | BJDX | HLSQ |
|---|---|---|
| Price | $2.15 | $0.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 155.8K | ★ 292.0K |
| Earning Date | 11-17-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.65 | ★ 560.42 |
| EPS | N/A | ★ 3.56 |
| Revenue | ★ $249,040.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.04 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.15 |
| 52 Week High | $30.52 | $7.70 |
| Indicator | BJDX | HLSQ |
|---|---|---|
| Relative Strength Index (RSI) | 85.62 | 9.04 |
| Support Level | $0.80 | N/A |
| Resistance Level | $4.19 | $2.85 |
| Average True Range (ATR) | 0.08 | 0.32 |
| MACD | 0.10 | -0.00 |
| Stochastic Oscillator | 85.07 | 0.63 |
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Tessera Defense and Homeland Security Inc develops and acquires technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response markets - building a portfolio around the growing need for earlier, more accurate threat detection as UAVs and other autonomous systems reshape the operating environment. The Company's portfolio includes Zorronet, an AI-powered autonomous command-and-control platform, and DFSL, a developer of LADAR-based counter-UAS and perimeter security systems.